Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vyndaqel
Vyndaqel
Pfizer Announces Publication of New Analysis Showing Long-Term Therapy with VYNDAQEL (tafamidis) Slowed Progression of Rare Neurodegenerative Disease
Yahoo
Mon, 08/8/16 - 09:57 am
Pfizer
Vyndaqel
tafamidis
TTR-FAP
Pfizer says FDA wants a new study of Vyndaqel
Yahoo/AP
Mon, 06/18/12 - 09:21 pm
FDA
Pfizer
Vyndaqel
familial amyloid polyneuropathy
FDA staff shoots down Pfizer rare disease drug
Yahoo/Reuters
Tue, 05/22/12 - 11:19 am
FDA
Pfizer
Vyndaqel
familial amyloid polyneuropathy
Pfizer, Gilead Sciences, Arena Pharmaceuticals Face Big Dates in May
Minyanville
Mon, 04/30/12 - 10:12 pm
Pfizer
Arena Pharmaceuticals
Gilead Sciences
Vyndaqel
JNJ
Xarelto
ASCO
Talon Therapeutics
Marqibo
Quad
Truvada
lorcaserin
Protalix BioTherapeutics
Alexza
Adasuve
Arcalyst
Regeneron
Abbott Laboratories
Remicade
EU Approval for Pfizer Drug
Yahoo/Zacks
Sat, 11/19/11 - 12:20 pm
Vyndaqel
Pfizer
transthyretin familial amyloid polyneuropathy
Pfizer's rare disease drug gets EU nod
Reuters
Thu, 11/17/11 - 08:58 am
Pfizer
Europe
Vyndaqel
transthyretin familial amyloid polyneuropathy
Pages
« first
‹ previous
1
2
